Literature DB >> 696335

Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.

S Lange, J Holmgren.   

Abstract

An adult mouse model has been elaborated for studies of experimental cholera (Vibrio cholerae enterotoxin-induced intestinal secretion) and protective antitoxic immunity in either ligated small bowel loops or intact small intestine. Mice of different inbred strains varied markedly in intestinal susceptibility to toxin, C57B1 being the most sensitive strain tested. Fluid accumulation started within 1 h after the inoculation of toxin and was maximal after 5 h, whereafter recovery gradually ensued. The dose-response curve was sigmoid, the ED50 of crude toxin being equivalent to about 0.1 microgram purified toxin/cm in the loops and 0.3 microgram/cm in the nonligated intestine. Two peroral (p.o.) immunizations induced significant protective immunity which increased markedly after two further immunizations by the same route. Additional p.o. immunizations did not appreciably enhance the protective immunity any further. Intravenous (i.v.) vaccination had to be repeated more than 5 times before intestinal immunity could be observed. No correlation between serum antitoxin titers and protective immunity was found. Electron microscopic examination revealed that whereas peroxidase-coupled cholera toxin bound tightly to intestinal microvilli from unimmunized or 5-times i.v. immunized mice it did not bind to the microvilli of p.o. immunized animals. The data thus suggest that the protective immunity is mediated exclusively by locally produced antibodies which prevent the binding to toxin to the gut epithelium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 696335     DOI: 10.1111/j.1699-0463.1978.tb02572.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  30 in total

1.  Cholera toxin induces a transient depletion of CD8+ intraepithelial lymphocytes in the rat small intestine as detected by microarray and immunohistochemistry.

Authors:  Carl-Fredrik Flach; Stefan Lange; Eva Jennische; Ivar Lönnroth; Jan Holmgren
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Host defense against cholera toxin is strongly CD4+ T cell dependent.

Authors:  E Hörnqvist; T J Goldschmidt; R Holmdahl; N Lycke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Oral vaccines: directed safe passage to the front line of defense.

Authors:  Qing Zhu; Jay A Berzofsky
Journal:  Gut Microbes       Date:  2013-03-14

4.  Local cholera immunity in mice: intestinal antitoxin-containing cells and their correlation with protective immunity.

Authors:  S Lange; H A Hansson; S O Molin; H Nygren
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

5.  Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

Authors:  M Kjerrulf; D Grdic; L Ekman; K Schön; M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

6.  Changes in intestinal fluid and mucosal immune responses to cholera toxin in Giardia muris infection and binding of cholera toxin to Giardia muris trophozoites.

Authors:  I Ljungström; J Holmgren; A M Svennerholm; A Ferrante
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation.

Authors:  T Nakaki; T Nakadate; S Yamamoto; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

8.  IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ.

Authors:  T Tamaru; W R Brown
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

9.  A mucosal antibody response following systemic Haemophilus influenzae type B infection in children.

Authors:  M E Pichichero; C B Hall; R A Insel
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Generation of antibodies reactive with fumonisins B1, B2, and B3 by using cholera toxin as the carrier-adjuvant.

Authors:  J I Azcona-Olivera; M M Abouzied; R D Plattner; W P Norred; J J Pestka
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.